» Articles » PMID: 33175145

SARS-CoV-2 Seroprevalence and Antibody Kinetics Among Health Care Workers in a Spanish Hospital After 3 Months of Follow-up

Abstract

Background: At the COVID-19 spring 2020 pandemic peak in Spain, prevalence of SARS-CoV-2 infection in a cohort of 578 randomly selected health care workers (HCWs) from Hospital Clínic de Barcelona was 11.2%.

Methods: A follow-up survey 1 month later (April-May 2020) measured infection by rRT-PCR and IgM, IgA, and IgG to the receptor-binding domain of the spike protein by Luminex. Antibody kinetics, including IgG subclasses, was assessed until month 3.

Results: At month 1, the prevalence of infection measured by rRT-PCR and serology was 14.9% (84/565) and seroprevalence 14.5% (82/565). We found 25 (5%) new infections in 501 participants without previous evidence of infection. IgM, IgG, and IgA levels declined in 3 months (antibody decay rates 0.15 [95% CI, .11-.19], 0.66 [95% CI, .54-.82], and 0.12 [95% CI, .09-.16], respectively), and 68.33% of HCWs had seroreverted for IgM, 3.08% for IgG, and 24.29% for IgA. The most frequent subclass responses were IgG1 (highest levels) and IgG2, followed by IgG3, and only IgA1 but no IgA2 was detected.

Conclusions: Continuous and improved surveillance of SARS-CoV-2 infections in HCWs remains critical, particularly in high-risk groups. The observed fast decay of IgA and IgM levels has implications for seroprevalence studies using these isotypes.

Citing Articles

Seroprevalence of SARS-COV-2 Antibodies Associated with the Use of Personal Protective Equipment in Healthcare Workers.

Dubinovic-Rekic A, Pranjic N Mater Sociomed. 2025; 36(3):222-228.

PMID: 39749151 PMC: 11693126. DOI: 10.5455/msm.2024.36.222-228.


Analytical measuring interval, linearity, and precision of serology assays for detection of SARS-CoV-2 antibodies according to CLSI guidelines.

Haynesworth K, Kemp T, Loftus S, Metz J, Castro N, Bullock J mSphere. 2024; 9(11):e0039324.

PMID: 39480103 PMC: 11580426. DOI: 10.1128/msphere.00393-24.


Correlates of protection and determinants of SARS-CoV-2 breakthrough infections 1 year after third dose vaccination.

Martin Perez C, Aguilar R, Jimenez A, Salmeron G, Canyelles M, Rubio R BMC Med. 2024; 22(1):103.

PMID: 38454385 PMC: 10921636. DOI: 10.1186/s12916-024-03304-3.


Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Responses After Community Infections in Children and Adults.

Dawood F, Couture A, Zhang X, Stockwell M, Porucznik C, Stanford J Open Forum Infect Dis. 2023; 10(5):ofad168.

PMID: 37213425 PMC: 10199115. DOI: 10.1093/ofid/ofad168.


Antigen-Specific Antibody Signature Is Associated with COVID-19 Outcome.

Salgado B, Jordao M, de Morais T, da Silva D, Pereira Filho I, Salgado Sobrinho W Viruses. 2023; 15(4).

PMID: 37112998 PMC: 10143282. DOI: 10.3390/v15041018.


References
1.
Collins A, Jackson K . A Temporal Model of Human IgE and IgG Antibody Function. Front Immunol. 2013; 4:235. PMC: 3738878. DOI: 10.3389/fimmu.2013.00235. View

2.
Amanat F, Stadlbauer D, Strohmeier S, Nguyen T, Chromikova V, McMahon M . A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 2020; 26(7):1033-1036. PMC: 8183627. DOI: 10.1038/s41591-020-0913-5. View

3.
Barth W, WOCHNER R, Waldmann T, Fahey J . METABOLISM OF HUMAN GAMMA MACROGLOBULINS. J Clin Invest. 1964; 43:1036-48. PMC: 289584. DOI: 10.1172/JCI104987. View

4.
Houlihan C, Vora N, Byrne T, Lewer D, Kelly G, Heaney J . Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers. Lancet. 2020; 396(10246):e6-e7. PMC: 7347344. DOI: 10.1016/S0140-6736(20)31484-7. View

5.
Lai X, Wang M, Qin C, Tan L, Ran L, Chen D . Coronavirus Disease 2019 (COVID-2019) Infection Among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital in Wuhan, China. JAMA Netw Open. 2020; 3(5):e209666. PMC: 7243089. DOI: 10.1001/jamanetworkopen.2020.9666. View